© Brian Kinney/Shutterstock.com
EBMT Satellite Symposium supported by Miltenyi Biotec
Cell therapy: Emerging strategies
and future visions
42nd Annual Meeting of the EBMT
Valencia, Spain
Sunday, April 3, 2016
13:30–15:30
Feria Valencia-Convention & Exhibition Centre
Auditorium 1A
Agenda
Chair:
Jose M Moraleda, Murcia, Spain
13:30–13:40Welcome
Jose M Moraleda, Murcia, Spain
13:40–14:00Immune recovery after TcR alpha/beta-depleted haploidentical stem cell transplantation
Rupert Handgretinger, Tübingen, Germany
14:00–14:20Haploidentical hematopoietic stem cell transplantation using TcR alpha/beta/CD19 based
selection in children with leukemia: a prospective study
Marta Gonzalez Vicent, Madrid, Spain
14:20–14:40Fighting infections in HSCT – adoptive memory T cell DLI in haploidentical and matched
unrelated HSCT
Michael Maschan, Moscow, Russia
14:40–15:00Combining adoptive and in vitro Regulatory T cell enhancement for clinical therapeutics
John Koreth, Boston, USA
15:00–15:20Automated CAR T cell engineering using the CliniMACS Prodigy® System
Waseem Qasim, London, UK
15:20–15:30Concluding remarks
Jose M Moraleda, Murcia, Spain
miltenyibiotec.com
Unless otherwise specifically indicated, Miltenyi Biotec products are for research use only and not for therapeutic or diagnostic use. CliniMACS® Reagents, Tubing
Sets, Instruments, and PBS/EDTA Buffer are manufactured and controlled under an ISO 13485 certified quality system. In Europe, the CliniMACS System and
Reagents are available as CE-marked medical devices. In the US, the CliniMACS CD34 Reagent System, including the CliniMACS Plus Instrument, CliniMACS CD34
Reagent, CliniMACS Tubing Set TS and LS, and the CliniMACS PBS/EDTA Buffer, is FDA approved; all other products of the CliniMACS product line are available for
use only under an approved Investigational New Drug (IND) application or Investigational Device Exemption (IDE). CliniMACS® MicroBeads are for research use
only and not for use in humans. The statements, publications and other contributions presented at the workshop and/or in this document and the views expressed
therein are those of the attending experts and do not necessarily represent the policy or opinion of Miltenyi Biotec or any institution the respective expert may be
associated with. Neither Miltenyi Biotec, nor any of its directors, or employees give any representation or warranty as to the reliability, accuracy or completeness
of the content thereof. This notice must accompany any further distribution of this document. CliniMACS, CliniMACS Prodigy, MACS, and TexMACS are trademarks
or registered trademarks of Miltenyi Biotec GmbH. This document may not be reproduced or distributed in any form in whole or in part without the prior written
permission of the authors and Miltenyi Biotec. Copyright © 2016 Miltenyi Biotec GmbH. All rights reserved.